The Delhi High Court Tuesday sought a response from Novo Nordisk as to why its patent on diabetes and anti-obesity drug semaglutide should not be revoked-a direction sought by ...
New Delhi: Natco Pharma on Tuesday said it has received a warning letter from the US health regulator for its Telangana-based manufacturing plant. The US Food and Drug Administration ...